 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PZOO Subsidiary MA & Associates, LLC Begins Processing Test Samples |
|
 Hot Stock to Watch |
Company: Pazoo, Inc. (Pink Sheets: PZOO)
|
Last:
Price: 0.0003
Change (%): + 0.0001 (50.00)
Volume: 7,502,666 |
 |
Pazoo, Inc. Subsidiary MA & Associates, LLC Begins Processing Test Samples
FLORHAM PARK, N.J., April 24, 2017 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) is pleased to announce that its subsidiary MA & Associates, LLC (MA), a cannabis testing lab in Las Vegas, Nevada, is processing simulated prodigal samples through all state-required medical marijuana tests in an effort to fine-tune all methods and to prepare for processing all types of medical marijuana samples. Perfecting the methods used for medical marijuana products such as edibles, topicals, and non-solvent extracts is the top priority, after which the lab will focus on finalizing methods for all usable marijuana.
MA’s lab staff and director have been tirelessly working on establishing the most cost-effective and efficient methodologies to ensure the lab provides accurate, reasonably priced results, with a rapid turnaround time, in order to provide our customers with the best service possible.
CEO of Pazoo, David Cunic, stated, “We are very excited about testing these samples using simulated prodigal. We are ensuring that the results are accurate and making sure that the job is done right the first time. Many people are unaware that Nevada has the most stringent testing rules and regulations in the country. It is one of the reasons why industry experts consider the testing labs in Nevada to be at the fore-front of the cannabis testing lab sector in America. Overall, we are today’s pioneers, helping to educate and empower other states about the critical importance of stringent testing and what tests should be performed to ensure patients have the safest and most reliable products possible.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
